{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:34:22Z","timestamp":1792197262627,"version":"4.4.0"},"reference-count":145,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009447","name":"Leukemia and Lymphoma Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022706","name":"Cole Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-186019"],"award-info":[{"award-number":["PJT-186019"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cell Biology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.tcb.2025.04.006","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:06:33Z","timestamp":1747958793000},"page":"971-986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Translational control of leukemic metabolism and disease progression"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5324-2167","authenticated-orcid":false,"given":"Fran\u00e7ois E.","family":"Mercier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Gife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6812-497X","authenticated-orcid":false,"given":"Raquel","family":"Aloyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7585-7760","authenticated-orcid":false,"given":"Laura","family":"Hulea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcb.2025.04.006_bb0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.tcb.2025.04.006_bb0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/17474086.2021.1875814","article-title":"A review of FDA-approved acute myeloid leukemia therapies beyond \u20187 + 3\u2019","volume":"14","author":"Bazinet","year":"2021","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0015","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2025.04.006_bb0020","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.tcb.2025.04.006_bb0025","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Dohner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2025.04.006_bb0030","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1182\/blood-2016-10-696054","article-title":"Biology and relevance of human acute myeloid leukemia stem cells","volume":"129","author":"Thomas","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2025.04.006_bb0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2025.04.006_bb0040","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1038\/s41586-019-1475-x","article-title":"Publisher correction: absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion","volume":"572","author":"Paczulla","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2025.04.006_bb0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41586-019-1835-6","article-title":"HBO1 is required for the maintenance of leukaemia stem cells","volume":"577","author":"MacPherson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2025.04.006_bb0050","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2025.04.006_bb0055","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","article-title":"Inhibition of amino acid metabolism selectively targets human leukemia stem cells","volume":"34","author":"Jones","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0060","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.stem.2021.06.004","article-title":"Nicotinamide phosphoribosyltransferase inhibitors selectively induce apoptosis of AML stem cells by disrupting lipid homeostasis","volume":"28","author":"Subedi","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0065","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2025.04.006_bb0070","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/s41375-024-02211-z","article-title":"Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity","volume":"38","author":"Schwede","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.tcb.2025.04.006_bb0075","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41580-023-00624-9","article-title":"The molecular basis of translation initiation and its regulation in eukaryotes","volume":"25","author":"Brito Querido","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0080","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1128\/MCB.19.3.1871","article-title":"Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo","volume":"19","author":"Waskiewicz","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00070-18","article-title":"Signaling pathways involved in the regulation of mRNA translation","volume":"38","author":"Roux","year":"2018","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0090","doi-asserted-by":"crossref","first-page":"8550","DOI":"10.1073\/pnas.87.21.8550","article-title":"Molecular structure of a major insulin\/mitogen-activated 70-kDa S6 protein kinase","volume":"87","author":"Banerjee","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tcb.2025.04.006_bb0095","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cell.2005.10.024","article-title":"mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events","volume":"123","author":"Holz","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0100","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.1130276","article-title":"S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth","volume":"314","author":"Dorrello","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tcb.2025.04.006_bb0105","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1158\/0008-5472.CAN-05-3469","article-title":"Akt phosphorylates and regulates Pdcd4 tumor suppressor protein","volume":"65","author":"Palamarchuk","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.tcb.2025.04.006_bb0110","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1093\/emboj\/20.16.4370","article-title":"Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase","volume":"20","author":"Wang","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.tcb.2025.04.006_bb0115","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bbagrm.2015.02.005","article-title":"A liaison between mTOR signaling, ribosome biogenesis and cancer","volume":"1849","author":"Gentilella","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tcb.2025.04.006_bb0120","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1093\/nar\/gkaa1239","article-title":"mTORC1 promotes TOP mRNA translation through site-specific phosphorylation of LARP1","volume":"49","author":"Jia","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tcb.2025.04.006_bb0125","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3390\/cancers14092126","article-title":"Targeting ribosome biogenesis in cancer: lessons learned and way forward","volume":"14","author":"Zisi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tcb.2025.04.006_bb0130","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1530\/JME-18-0058","article-title":"Oncogenic kinases and perturbations in protein synthesis machinery and energetics in neoplasia","volume":"62","author":"Uchenunu","year":"2019","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0135","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmet.2018.09.001","article-title":"Translational and HIF-1alpha-dependent metabolic reprogramming underpin metabolic plasticity and responses to kinase inhibitors and biguanides","volume":"28","author":"Hulea","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.tcb.2025.04.006_bb0140","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.tcb.2016.06.005","article-title":"Translation initiation factors: reprogramming protein synthesis in cancer","volume":"26","author":"Chu","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0145","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1080\/15476286.2017.1290041","article-title":"mTOR-sensitive translation: cleared fog reveals more trees","volume":"14","author":"Masvidal","year":"2017","journal-title":"RNA Biol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0150","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1101\/gr.197566.115","article-title":"nanoCAGE reveals 5\u2032 UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs","volume":"26","author":"Gandin","year":"2016","journal-title":"Genome Res."},{"key":"10.1016\/j.tcb.2025.04.006_bb0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nature12830","article-title":"Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness","volume":"504","author":"Li","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2025.04.006_bb0160","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1182\/blood-2013-08-521708","article-title":"NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemia","volume":"124","author":"Sachs","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2025.04.006_bb0165","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1152\/physrev.00029.2018","article-title":"FMS-like tyrosine kinase 3\/FLT3: from basic science to clinical implications","volume":"99","author":"Kazi","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tcb.2025.04.006_bb0170","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/bjh.15578","article-title":"Direct role of FLT3 in regulation of early lymphoid progenitors","volume":"183","author":"Zriwil","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0175","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-023-01721-1","article-title":"Targeting Pim kinases in hematological cancers: molecular and clinical review","volume":"22","author":"Bellon","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tcb.2025.04.006_bb0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood-2009-02-205153","article-title":"Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin","volume":"114","author":"Assouline","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2025.04.006_bb0185","doi-asserted-by":"crossref","first-page":"371","DOI":"10.18632\/oncotarget.477","article-title":"Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment","volume":"3","author":"Martelli","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.tcb.2025.04.006_bb0190","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.cmet.2024.07.022","article-title":"The crosstalk between metabolism and translation","volume":"36","author":"Biffo","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.tcb.2025.04.006_bb0195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/bj3120163","article-title":"A hierarchy of ATP-consuming processes in mammalian cells","volume":"312","author":"Buttgereit","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.tcb.2025.04.006_bb0200","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011528","article-title":"Principles of translational control: an overview","volume":"4","author":"Hershey","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0205","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.stem.2015.08.019","article-title":"AMPK protects leukemia-initiating cells in myeloid leukemias from metabolic stress in the bone marrow","volume":"17","author":"Saito","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0210","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood-2014-08-594408","article-title":"AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress","volume":"125","author":"Sriskanthadevan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2025.04.006_bb0215","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ccell.2022.02.006","article-title":"The proteogenomic subtypes of acute myeloid leukemia","volume":"40","author":"Jayavelu","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0220","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tcb.2025.04.006_bb0225","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccell.2018.08.007","article-title":"Identification of chemotherapy-induced leukemic-regenerating cells reveals a transient vulnerability of human AML recurrence","volume":"34","author":"Boyd","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0230","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.18632\/oncotarget.13650","article-title":"Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia","volume":"8","author":"Yan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tcb.2025.04.006_bb0235","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s43018-021-00264-y","article-title":"Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia","volume":"2","author":"Bosc","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.tcb.2025.04.006_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.765973","article-title":"Inhibition of the anti-apoptotic Bcl-2 family by BH3 mimetics sensitize the mitochondrial permeability transition pore through Bax and Bak","volume":"9","author":"Patel","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0245","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ccell.2019.06.003","article-title":"Mubritinib targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia","volume":"36","author":"Baccelli","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0250","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","article-title":"Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia","volume":"20","author":"Skrtic","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","article-title":"Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials","volume":"29","author":"Yap","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.tcb.2025.04.006_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2024.100009","article-title":"Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trial","volume":"1","author":"Pardee","year":"2024","journal-title":"Blood Neoplasia"},{"key":"10.1016\/j.tcb.2025.04.006_bb0265","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41392-020-00326-0","article-title":"NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications","volume":"5","author":"Ju","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tcb.2025.04.006_bb0270","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.stem.2020.07.021","article-title":"Nicotinamide metabolism mediates resistance to venetoclax in relapsed acute myeloid leukemia stem cells","volume":"27","author":"Jones","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0275","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.cmet.2024.01.013","article-title":"SLC25A51 decouples the mitochondrial NAD+\/NADH ratio to control proliferation of AML cells","volume":"36","author":"Lu","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.tcb.2025.04.006_bb0280","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1158\/2643-3230.BCD-20-0168","article-title":"Sirt5 Is a druggable metabolic vulnerability in acute myeloid leukemia","volume":"2","author":"Yan","year":"2021","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.tcb.2025.04.006_bb0285","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1182\/blood.2019898114","article-title":"Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II","volume":"134","author":"Jones","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2025.04.006_bb0290","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/s41375-022-01573-6","article-title":"Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia","volume":"36","author":"Pardieu","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.tcb.2025.04.006_bb0295","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1158\/1078-0432.CCR-18-3223","article-title":"Targeting glutamine metabolism and redox state for leukemia therapy","volume":"25","author":"Gregory","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tcb.2025.04.006_bb0300","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood.2019003654","article-title":"Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cells","volume":"136","author":"Raffel","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2025.04.006_bb0305","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ccell.2019.12.002","article-title":"Vitamin B6 addiction in acute myeloid leukemia","volume":"37","author":"Chen","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0310","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s43018-024-00811-3","article-title":"Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b\/2 clinical trial and correlative analyses","volume":"5","author":"DiNardo","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.tcb.2025.04.006_bb0315","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0320","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ccell.2019.01.013","article-title":"Inhibition of amino acid metabolism selectively targets human leukemia stem cells","volume":"35","author":"Jones","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0325","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","article-title":"Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells","volume":"1","author":"Stevens","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.tcb.2025.04.006_bb0330","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1182\/bloodadvances.2020002127","article-title":"Cell interactions in the bone marrow microenvironment affecting myeloid malignancies","volume":"4","author":"Kokkaliaris","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.tcb.2025.04.006_bb0335","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.trecan.2017.10.003","article-title":"Mitochondrial transfer in the leukemia microenvironment","volume":"3","author":"Griessinger","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.tcb.2025.04.006_bb0340","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75908","article-title":"Crosstalk between AML and stromal cells triggers acetate secretion through the metabolic rewiring of stromal cells","volume":"11","author":"Vilaplana-Lopera","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.tcb.2025.04.006_bb0345","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/bloodadvances.2020003661","article-title":"Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition","volume":"5","author":"Saito","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.tcb.2025.04.006_bb0350","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cmet.2020.09.001","article-title":"Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy","volume":"32","author":"Forte","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.tcb.2025.04.006_bb0355","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cmet.2020.07.009","article-title":"Induction of a timed metabolic collapse to overcome cancer chemoresistance","volume":"32","author":"van Gastel","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.tcb.2025.04.006_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110607","article-title":"NADPH metabolism determines the leukemogenic capacity and drug resistance of AML cells","volume":"39","author":"Chen","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tcb.2025.04.006_bb0365","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1111\/cas.15098","article-title":"Evi1 upregulates Fbp1 and supports progression of acute myeloid leukemia through pentose phosphate pathway activation","volume":"112","author":"Mizuno","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tcb.2025.04.006_bb0370","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140242","article-title":"Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models","volume":"131","author":"He","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tcb.2025.04.006_bb0375","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.matbio.2022.07.003","article-title":"Phosphorylation of eIF4E in the stroma drives the production and spatial organisation of collagen type I in the mammary gland","volume":"111","author":"Preston","year":"2022","journal-title":"Matrix Biol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0380","doi-asserted-by":"crossref","DOI":"10.1172\/JCI181575","article-title":"Inhibiting the MNK1\/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses","volume":"134","author":"Huang","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tcb.2025.04.006_bb0385","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1158\/2159-8290.CD-20-0738","article-title":"Serine biosynthesis is a metabolic vulnerability in FLT3-ITD-driven acute myeloid leukemia","volume":"11","author":"Bjelosevic","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tcb.2025.04.006_bb0390","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1158\/1535-7163.MCT-15-0163","article-title":"Antileukemic activity of 2-deoxy-d-glucose through inhibition of N-linked glycosylation in acute myeloid leukemia with FLT3-ITD or c-KIT mutations","volume":"14","author":"Larrue","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tcb.2025.04.006_bb0395","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1158\/1078-0432.CCR-14-2146","article-title":"Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations","volume":"21","author":"Alvarez-Calderon","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tcb.2025.04.006_bb0400","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1182\/blood-2008-12-196055","article-title":"FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation","volume":"114","author":"Yoshimoto","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2025.04.006_bb0405","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/bloodadvances.2020002981","article-title":"The metabolic reprogramming in acute myeloid leukemia patients depends on their genotype and is a prognostic marker","volume":"5","author":"Lo Presti","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.tcb.2025.04.006_bb0410","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s13046-022-02542-8","article-title":"EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax","volume":"41","author":"Fooks","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tcb.2025.04.006_bb0415","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.exphem.2022.01.006","article-title":"Translatome changes in acute myeloid leukemia cells post exposure to pegcrisantaspase and venetoclax","volume":"108","author":"Kapadia","year":"2022","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0420","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.cmet.2013.10.001","article-title":"mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation","volume":"18","author":"Morita","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.tcb.2025.04.006_bb0425","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.molcel.2017.08.013","article-title":"mTOR controls mitochondrial dynamics and cell survival via MTFP1","volume":"67","author":"Morita","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0430","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1038\/s41467-019-13086-5","article-title":"eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma","volume":"10","author":"Chan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2025.04.006_bb0435","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1038\/s41467-024-48386-y","article-title":"mTORC1 regulates cell survival under glucose starvation through 4EBP1\/2-mediated translational reprogramming of fatty acid metabolism","volume":"15","author":"Levy","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2025.04.006_bb0440","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41467-018-03028-y","article-title":"Fatty acid synthase induced S6 kinase facilitates USP11-eIF4B complex formation for sustained oncogenic translation in DLBCL","volume":"9","author":"Kapadia","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2025.04.006_bb2005","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1038\/s41467-024-46665-2","article-title":"Translation efficiency driven by CNOT3 subunit of the CCR4-NOT complex promotes leukemogenesis","volume":"15","author":"Ghashghaei","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2025.04.006_bb2010","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","article-title":"The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia","volume":"40","author":"Weng","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0445","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2318093121","article-title":"A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer","volume":"121","author":"Cencic","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tcb.2025.04.006_bb0450","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41467-020-20491-8","article-title":"Imaging dynamic mTORC1 pathway activity in vivo reveals marked shifts that support time-specific inhibitor therapy in AML","volume":"12","author":"Oki","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2025.04.006_bb0455","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1172\/JCI62279","article-title":"mTORC1 is essential for leukemia propagation but not stem cell self-renewal","volume":"122","author":"Hoshii","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tcb.2025.04.006_bb0460","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/leu.2014.123","article-title":"Feedbacks and adaptive capabilities of the PI3K\/Akt\/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis","volume":"28","author":"Bertacchini","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.tcb.2025.04.006_bb0465","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2007-03-080796","article-title":"Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase\/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways","volume":"111","author":"Tamburini","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2025.04.006_bb0470","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"O\u2019Reilly","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.tcb.2025.04.006_bb0475","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-12-2395","article-title":"eIF4E\/4E-BP ratio predicts the efficacy of mTOR targeted therapies","volume":"72","author":"Alain","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.tcb.2025.04.006_bb0480","first-page":"676","article-title":"mTORC1\/ERK1\/2 interplay regulates protein synthesis and survival in acute myeloid leukemia cell lines","volume":"12","author":"Germano","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.tcb.2025.04.006_bb0485","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020102118","article-title":"Adaptive responses to mTOR gene targeting in hematopoietic stem cells reveal a proliferative mechanism evasive to mTOR inhibition","volume":"118","author":"Fan","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tcb.2025.04.006_bb0490","doi-asserted-by":"crossref","first-page":"9189","DOI":"10.18632\/oncotarget.3279","article-title":"FLT3-ITD confers resistance to the PI3K\/Akt pathway inhibitors by protecting the mTOR\/4EBP1\/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia","volume":"6","author":"Nogami","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.tcb.2025.04.006_bb0495","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ccell.2021.06.003","article-title":"The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance","volume":"39","author":"Joshi","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0500","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3324\/haematol.2020.257964","article-title":"A genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways that mediate resistance to sorafenib in acute myeloid leukemia","volume":"107","author":"Damnernsawad","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.tcb.2025.04.006_bb0505","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1158\/2159-8290.CD-18-1453","article-title":"Clonal selection with RAS pathway activation mediates secondary clinical resistance to selective FLT3 inhibition in acute myeloid leukemia","volume":"9","author":"McMahon","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tcb.2025.04.006_bb0510","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1124\/mol.115.098012","article-title":"Pharmacologic inhibition of MNKs in acute myeloid leukemia","volume":"88","author":"Teo","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0515","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2016-02-698704","article-title":"Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo","volume":"128","author":"Kosciuczuk","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2025.04.006_bb0520","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1038\/s41375-021-01308-z","article-title":"Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML","volume":"35","author":"Nishida","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.tcb.2025.04.006_bb0525","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd4505","article-title":"Targeting the translation machinery in cancer","volume":"14","author":"Bhat","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tcb.2025.04.006_bb0530","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature17978","article-title":"Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor","volume":"534","author":"Iwasaki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2025.04.006_bb0535","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/2159-8290.CD-22-0210","article-title":"A dynamic rRNA ribomethylome drives stemness in acute myeloid leukemia","volume":"13","author":"Zhou","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tcb.2025.04.006_bb0540","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1182\/blood-2016-05-718171","article-title":"Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population","volume":"129","author":"Hein","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2025.04.006_bb0545","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41588-023-01602-9","article-title":"The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells","volume":"56","author":"Koh","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tcb.2025.04.006_bb0550","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1158\/2159-8290.CD-18-1455","article-title":"First-in-human RNA polymerase I transcription inhibitor CX-5461 in patients with advanced hematologic cancers: results of a phase I dose-escalation study","volume":"9","author":"Khot","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tcb.2025.04.006_bb0555","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf7561","article-title":"The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output","volume":"7","author":"Kanellis","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tcb.2025.04.006_bb0560","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41375-023-02098-2","article-title":"The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia","volume":"38","author":"Miliara","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.tcb.2025.04.006_bb0565","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1261\/rna.079318.122","article-title":"Exploring the targeting spectrum of rocaglates among eIF4A homologs","volume":"29","author":"Naineni","year":"2023","journal-title":"RNA"},{"key":"10.1016\/j.tcb.2025.04.006_bb0570","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41375-021-01393-0","article-title":"YBX1 mediates translation of oncogenic transcripts to control cell competition in AML","volume":"36","author":"Perner","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.tcb.2025.04.006_bb0575","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood.2020009676","article-title":"YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner","volume":"138","author":"Feng","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2025.04.006_bb0580","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.chembiol.2021.02.014","article-title":"Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer","volume":"28","author":"Tailor","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0585","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41586-023-06228-9","article-title":"Single-cell quantification of ribosome occupancy in early mouse development","volume":"618","author":"Ozadam","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2025.04.006_bb0590","doi-asserted-by":"crossref","first-page":"8260","DOI":"10.1038\/s41467-023-43917-5","article-title":"Single-cell spatial metabolomics with cell-type specific protein profiling for tissue systems biology","volume":"14","author":"Hu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2025.04.006_bb0595","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.3390\/ijms24076334","article-title":"Specialized ribosomes in health and disease","volume":"24","author":"Miller","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tcb.2025.04.006_bb0600","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcae012","article-title":"The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues","volume":"6","author":"Anazco-Guenkova","year":"2024","journal-title":"NAR Cancer"},{"key":"10.1016\/j.tcb.2025.04.006_bb0605","doi-asserted-by":"crossref","first-page":"8971","DOI":"10.3390\/ijms23168971","article-title":"Multiple roles of m6A RNA modification in translational regulation in cancer","volume":"23","author":"Fernandez Rodriguez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tcb.2025.04.006_bb0610","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcae026","article-title":"Non-canonical mRNA translation initiation in cell stress and cancer","volume":"6","author":"Mahe","year":"2024","journal-title":"NAR Cancer"},{"key":"10.1016\/j.tcb.2025.04.006_bb0615","first-page":"2813","article-title":"How I treat AML incorporating the updated classifications and guidelines","volume":"141","author":"El Chaer","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2025.04.006_bb0620","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","article-title":"The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia","volume":"615","author":"Issa","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2025.04.006_bb0625","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add3942","article-title":"Regulation of eIF4E guides a unique translational program to control erythroid maturation","volume":"8","author":"Forester","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tcb.2025.04.006_bb0630","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2018.02.036","article-title":"Ribosome levels selectively regulate translation and lineage commitment in human hematopoiesis","volume":"173","author":"Khajuria","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0635","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood.2023021901","article-title":"The ATF4-RPS19BP1 axis modulates ribosome biogenesis to promote erythropoiesis","volume":"144","author":"Zheng","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2025.04.006_bb0640","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125690","article-title":"MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction","volume":"5","author":"Belle","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.tcb.2025.04.006_bb0645","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41392-021-00728-8","article-title":"Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy","volume":"6","author":"Kang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tcb.2025.04.006_bb0650","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MOH.0000000000000816","article-title":"Transcription factor regulation of ribosomal RNA in hematopoiesis","volume":"31","author":"Paralkar","year":"2024","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0655","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3324\/haematol.2022.280831","article-title":"Meis1 supports leukemogenesis through stimulation of ribosomal biogenesis and Myc","volume":"107","author":"Garcia-Cuellar","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.tcb.2025.04.006_bb0660","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ncb3563","article-title":"AML1-ETO requires enhanced C\/D box snoRNA\/RNP formation to induce self-renewal and leukaemia","volume":"19","author":"Zhou","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0665","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/stem.2355","article-title":"Kras is required for adult hematopoiesis","volume":"34","author":"Damnernsawad","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.tcb.2025.04.006_bb0670","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3324\/haematol.2012.080424","article-title":"Mouse gene targeting reveals an essential role of mTOR in hematopoietic stem cell engraftment and hematopoiesis","volume":"98","author":"Guo","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.tcb.2025.04.006_bb0675","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.stem.2012.06.009","article-title":"mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis","volume":"11","author":"Kalaitzidis","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0680","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aam6641","article-title":"The metabolic regulator mTORC1 controls terminal myeloid differentiation","volume":"2","author":"Lee","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.tcb.2025.04.006_bb0685","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1172\/JCI84565","article-title":"S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenance","volume":"126","author":"Ghosh","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tcb.2025.04.006_bb0690","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13035","article-title":"Haematopoietic stem cells require a highly regulated protein synthesis rate","volume":"509","author":"Signer","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2025.04.006_bb0695","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1101\/gad.282756.116","article-title":"The rate of protein synthesis in hematopoietic stem cells is limited partly by 4E-BPs","volume":"30","author":"Signer","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.tcb.2025.04.006_bb0700","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.stem.2012.05.026","article-title":"Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression","volume":"11","author":"Magee","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0705","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/leu.2016.223","article-title":"Rictor has a pivotal role in maintaining quiescence as well as stemness of leukemia stem cells in MLL-driven leukemia","volume":"31","author":"Fang","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.tcb.2025.04.006_bb0710","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cell.2011.07.032","article-title":"AKT\/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias","volume":"146","author":"Sykes","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2025.04.006_bb0715","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood.2022018092","article-title":"Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets","volume":"141","author":"Mishra","year":"2023","journal-title":"Blood"}],"container-title":["Trends in Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0962892425001084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0962892425001084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T17:52:57Z","timestamp":1762537977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0962892425001084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":145,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0962892425001084"],"URL":"https:\/\/doi.org\/10.1016\/j.tcb.2025.04.006","relation":{},"ISSN":["0962-8924"],"issn-type":[{"value":"0962-8924","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translational control of leukemic metabolism and disease progression","name":"articletitle","label":"Article Title"},{"value":"Trends in Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcb.2025.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}